Systemic activity of inhaled hydrofluoroalkane-134a metered dose inhaler with beclomethasone dipropionate in children with asthma

Pediatric Asthma, Allergy and Immunology

Volumn 19, Issue 3, 2006, Pages 172-179

  Wolthers, Ole D ^a  

^a Children's Clinic Randers   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CHLOROFLUOROCARBON; NORFLURANE;

ADOLESCENT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; METERED DOSE INHALER; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 33750937410     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.2006.19.172     Document Type: Article

References (21)

1. Brambilla G, Ganderton D, Garzia R, Lewis D, Meakin B, Ventura P. Modulation of aerosol clouds produced by pressurised inhalation aerosols. Int J Pharm 1999; 186:53-63.
2. Woodcock A, Acerbi D, Poli G. Modulite technology: pharmacodynamic and pharmacokinetic implications. Respir Med 2002; 96(Suppl D):S9-S15.
3. Vastagh E, Kuna P, Calistruc P, Bogdan MA. Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in-patients. Comparison with budesonide CFC. Respir Med 2003; 97 (Suppl F):S20-S28.
4. Lee TL, Adler L, McLaren G, Rossetti A, Cantini L. Assessment of efficacy and systemic safety of a new chlorofluorocarbon-free formulation of inhaled beclomethasone in asthmatic children. Pediatric Asthma Allergy Immunol 2002; 15:N3.
5. Chan IS. Proving non-inferiority or equivalence of two treatments with dichotomous endpoints using exact methods. Stat Methods Med Res 2003; 12:37-58.
6. Wolthers OD, Pedersen S. Short term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. Arch Dis Child 1993; 68:673-676.
7. Heuck C, Wolthers OD, Hansen M, Kollerup G. Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide. Steroids 1997; 62:659-664.
8. Heuck C, Wolthers OD, Kollerup G, Hansen M, Teisner B. Adverse effects of inhaled budesonide (800 μg) on growth and collagen turnover in children with asthma: a double blind comparison of once-daily versus twice-daily administration. J Fed 1998; 133:608-612.
9. Schou AJ, AM Plomgaard, K Thomsen, Wolthers OD. Suppression of lower leg growth in children treated with inhaled glucocorticoids is not accompanied by reduced thickness of cutis or subcutis. Acta Paediatr 2004; 93:623-627.
10. Tanner JM. 1962. The development of the reproductive system. In: Growth at adolescence. Blackwell, Oxford, pp. 28-39.
11. Wolthers OD. Methodological aspects of short-term knemometry in the assessment of exogenous glucocortisteroid-induced growth suppression in children. Ann Hum Biol 1997; 24:539-546.
12. Heuck C, Wolthers OD. Calculation of knemometric growth rates in group studies of children treated with exogenous glucocorticoids. Ann Hum Biol 1997; 24:411-418.
13. Honour JW. Urinary steroid profile analysis. Clin Chim Acta 2001; 313:45-50.
14. Fink RS, Pierre LN, Daley-Yates PT, Richards DH, Gibson A, Honour JW. Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation. J Clin Endocrinol Metab 2002; 87:4541-4546.
15. Wolthers OD, Pedersen S. Growth of asthmatic children during treatment with budesonide: a double blind trial. Br Med J 1991; 303:63-65.
16. Wolthers OD, Pedersen S. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics 1992; 89:839-842.
17. Wolthers OD. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a. J Pediatr Allergy Immunol. In press.
18. Daley-Yates PT, Price AC, Sisson JR, Pereira A, Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 2001; 51:400-409.
19. Goldberg S, Algur N, Levi M, Brukheimer E, Hirsch HJ, Branski D, Kerem E. Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroid with and without spacer device. Ann Allergy Asthma Immunol 1996; 76:234-238.
20. Thorsson L, Edsbacker S, Conradsen TB. Lung deposition of budesonide from turbohaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur Resp 94; 7:1839-1844.
21. Wolthers OD, Honour JW. Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications. J Asthma 1999; 36:477-486.